Dog Cancer: Welfare and Treatment Decisions

Cancer is the leading cause of death in dogs over age ten, and navigating treatment decisions requires balancing quality of life, welfare, and realistic prognosis.

Key Facts

Approximately one in three dogs will develop cancer during their lifetime.
Mast cell tumours, lymphoma, osteosarcoma, and haemangiosarcoma are among the most common diagnoses.
Osteosarcoma causes severe bone pain and typically carries a poor prognosis despite aggressive treatment.
Veterinary oncology has advanced significantly, with chemotherapy, surgery, and immunotherapy available.
Quality of life must be the primary consideration in treatment decisions for canine cancer patients.

Welfare Considerations

Cancer diagnosis in dogs raises complex welfare and ethical decisions. Aggressive treatment can extend life but must be balanced against treatment burden and quality of life during therapy. Dogs with cancer should receive adequate pain management throughout. Quality of life assessment tools help owners and vets evaluate whether treatment is maintaining or reducing welfare. The decision to pursue palliative care or euthanasia rather than aggressive treatment is sometimes the most welfare-positive choice and should be made collaboratively.

What You Can Do

Pursue regular veterinary checks from age seven to detect cancer at earlier, more treatable stages.
Work with a veterinary oncologist to understand realistic prognosis and treatment options.
Prioritise quality of life assessment tools when evaluating treatment continuation.
Ensure adequate pain management throughout any cancer treatment programme.
Discuss end-of-life planning early in the diagnosis to avoid delayed euthanasia causing unnecessary suffering.